AUPH Equity Alert: ROSEN, Top Ranked Investor Counsel, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH

WHY: New York, N.Y., March 23, 2022. Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) resulting from allegations that Aurinia may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Aurinia securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=3851 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On February 28, 2022, Aurinia issued a press release announcing its financial results for the quarter and full year ended December 31, 2021. Among other items, Aurinia reported a year-over-year revenue decline and announced a lower-than-expected sales outlook for 2022.

On this news, Aurinia's stock price fell $3.94 per share, or 24%, to close at $12.30 per share on February 28, 2022, damaging investors.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/117933

News Provided by Newsfile via QuoteMedia

AUP:CA,AUPH
The Conversation (0)
Exceptional silver and cobalt assays from seaweed

Exceptional silver and cobalt assays from seaweed

BPH Global (BP8:AU) has announced Exceptional silver and cobalt assays from seaweed

Download the PDF here.

Cizzle Brands Expands its Western Canadian Footprint With All Calgary Co-op and Freson Bros. Stores Now Selling CWENCH Hydration

Cizzle Brands Expands its Western Canadian Footprint With All Calgary Co-op and Freson Bros. Stores Now Selling CWENCH Hydration

As the CWENCH Hydrationâ„¢ brand continues to gain popularity, Cizzle Brands is strategically adding new retailers in select North American markets. Calgary Co-op and Freson Bros. are both chains of supermarkets in Alberta, and are expected to play a key role in building out the presence of CWENCH Hydrationâ„¢ in Western Canada.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death - key underlying mechanisms in heart failure

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announced today the publication of research in the Journal of the American College of Cardiology: Basic to Translational Science ("JACBTS"), titled "Cannabidiol Prevents Heart Failure Dysfunction and Remodeling Through Preservation of Mitochondrial Function and Calcium Handling" (www.jacc.orgdoiabs10.1016j.jacbts.2024.12.009). This research was conducted by scientists from Tecnológico de Monterrey who, together with researchers from the DeBakey Heart and Vascular Center in Houston, TX, are collaborating with Cardiol on the development of the Company's proprietary subcutaneous ("SubQ") formulation of cannabidiol, CRD-38, to treat heart failure with preserved ejection fraction. This common form of heart failure remains a leading cause of hospitalization worldwide and is associated with a five-year mortality that exceeds 75% in hospitalized patients.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

With a strong presence in British Columbia and Alberta and locations in Saskatchewan, Manitoba, New Brunswick, as well as Ontario, the availability of CWENCH Hydrationâ„¢ at all Canco locations enhances the brand's footprint across Canada in the key category of convenience retail.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

With a strong presence in British Columbia and Alberta and locations in Saskatchewan, Manitoba, New Brunswick, as well as Ontario, the availability of CWENCH Hydrationâ„¢ at all Canco locations enhances the brand's footprint across Canada in the key category of convenience retail.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

With a strong presence in British Columbia and Alberta and locations in Saskatchewan, Manitoba, New Brunswick, as well as Ontario, the availability of CWENCH Hydrationâ„¢ at all Canco locations enhances the brand's footprint across Canada in the key category of convenience retail.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×